1. Home
  2. IRS vs NVAX Comparison

IRS vs NVAX Comparison

Compare IRS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRS
  • NVAX
  • Stock Information
  • Founded
  • IRS 1943
  • NVAX 1987
  • Country
  • IRS Argentina
  • NVAX United States
  • Employees
  • IRS N/A
  • NVAX N/A
  • Industry
  • IRS Homebuilding
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IRS Real Estate
  • NVAX Health Care
  • Exchange
  • IRS Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • IRS 1.2B
  • NVAX 1.1B
  • IPO Year
  • IRS 1994
  • NVAX 1995
  • Fundamental
  • Price
  • IRS $13.93
  • NVAX $6.59
  • Analyst Decision
  • IRS
  • NVAX Hold
  • Analyst Count
  • IRS 0
  • NVAX 9
  • Target Price
  • IRS N/A
  • NVAX $10.78
  • AVG Volume (30 Days)
  • IRS 282.1K
  • NVAX 4.4M
  • Earning Date
  • IRS 11-06-2025
  • NVAX 11-06-2025
  • Dividend Yield
  • IRS 6.28%
  • NVAX N/A
  • EPS Growth
  • IRS N/A
  • NVAX N/A
  • EPS
  • IRS 0.42
  • NVAX 2.07
  • Revenue
  • IRS $370,153,377.00
  • NVAX $1,064,651,000.00
  • Revenue This Year
  • IRS N/A
  • NVAX $59.49
  • Revenue Next Year
  • IRS N/A
  • NVAX N/A
  • P/E Ratio
  • IRS $3.37
  • NVAX $3.12
  • Revenue Growth
  • IRS N/A
  • NVAX 20.27
  • 52 Week Low
  • IRS $10.61
  • NVAX $5.01
  • 52 Week High
  • IRS $17.67
  • NVAX $11.55
  • Technical
  • Relative Strength Index (RSI)
  • IRS 43.75
  • NVAX 35.05
  • Support Level
  • IRS $15.00
  • NVAX $6.20
  • Resistance Level
  • IRS $17.21
  • NVAX $6.80
  • Average True Range (ATR)
  • IRS 0.82
  • NVAX 0.35
  • MACD
  • IRS -0.13
  • NVAX -0.08
  • Stochastic Oscillator
  • IRS 4.08
  • NVAX 22.94

About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)

IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: